Simon Portsmouth | Pharmacologic Data on New and Pipeline Drugs - Shionogi Inc.

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Alice Pau | A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Elin Lindhagen | Harmonization of DDI Guidelines Among Different Regulatory Agencies: Challenges and Opportunities

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Catia Marzolini | Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ?

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Mike Emerson | Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Dario Cattaneo | Case Presentation - Complex DDI case

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Emma Rubenstein | A Year of CAB/RPV Use, What Have We Learned in the Real World

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Catriona Waitt | New(er) Antiretrovirals in Pregnancy and Breastfeeding

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Catherine Chappell | Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Lauren Walker | The Use of AI in Clinical Pharmacology

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Andrea Calcagno | Opening Lecture: News in Antiviral Pharmacology: A Year in Review

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Endogeneous Retroviruses and Inflammation - Yasmine Belkaid, PhD

Viral Infections & Inflammation Workshop 2023

Summary Video for Clinicians - Roger Paredes, PhD

Viral Infections & Inflammation Workshop 2023

Inflammasome Activation in Severe Cases of COVID-19 - Dario Zamboni, PhD

Viral Infections & Inflammation Workshop 2023

Developing CAR T Cells for Use in Chronic HIV Infection - Martin Tolstrup, MSc, PhD

Viral Infections & Inflammation Workshop 2023

The Plasma Microbiome Contributes to Immune Reconstitution in HIV Infected Individuals on Suppressive ART - Wei Jiang

Viral Infections & Inflammation Workshop 2023

HIV, Inflammation, and Macrophages - Maureen M. Goodenow, PhD

Viral Infections & Inflammation Workshop 2023

Possible Role of Intestinal Damage and Endotoxemia in the Development of Endotholial Dysfunction, Thrombosis and Secondary Lung Damage in Patients with COVID-19 - Liudmyla Shostakovych-Koretskaya

Viral Infections & Inflammation Workshop 2023

HIV Exposed Uninfected (Heu) Infants Have Pro-inflammatory Bioprofiles That Correlate with Their Mothers’ Bioprofiles Independent of Viral Levels and Persist for at Least Six Months - Li Yin

Viral Infections & Inflammation Workshop 2023

Post-acute Sequelae following Ebola infection - David Wohl, MD

Viral Infections & Inflammation Workshop 2023

What We Know Now about HIV and Long COVID - Annie Antar, MD, PhD

Viral Infections & Inflammation Workshop 2023

Epstein–Barr Virus and Multiple Sclerosis: Which Mechanisms are at Play? - Tobias Lanz, MD

Viral Infections & Inflammation Workshop 2023

Immunopathology of viral encephalitis - Avindra Nath, MD

Viral Infections & Inflammation Workshop 2023

Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study - Roger Paredes, PhD

Viral Infections & Inflammation Workshop 2023